Some links on this site are affiliate links. We may earn a commission when you sign up or buy through them, at no extra cost to you. Editorial coverage is not influenced by these relationships. Learn more.
Vessel
weight

Best GLP-1 Telehealth Programs of 2026 — Reviewed and Compared

We compared the leading GLP-1 telehealth programs on price, clinician quality, medication options, and shipping. Here's what we found.

Vessel Editors · Apr 15, 2026 · 9 min read

GLP-1 medications — semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) — have changed how clinicians think about weight management. Telehealth platforms made them more accessible than ever in 2023 and 2024, riding the FDA shortage that allowed compounding pharmacies to produce them at scale.

In 2025 the shortage formally ended, which reshaped the category. Some platforms pivoted to branded medications. Others kept compounding under tighter rules. Pricing, eligibility, and the patient experience now differ more than they ever have.

If you're considering a GLP-1 program, the question isn't really "which medication?" — your clinician decides that. The real question is which platform gives you the best clinical experience, pricing, and ongoing support.

What we looked at

Every program below was evaluated on five things:

  1. Pricing transparency — is the monthly cost upfront, or are there surprise fees?
  2. Clinician access — how quickly can you get a real clinician on the line if something feels off?
  3. Medication choices — compounded only, branded only, or both?
  4. Insurance acceptance — most are self-pay, but a few work with insurance.
  5. Patient experience — onboarding, app, communication, shipping.

We didn't rank brands by who pays the highest commission. The "Editor's pick" tag goes to whoever we'd genuinely recommend to a friend.

How GLP-1 medications work (briefly)

GLP-1 receptor agonists mimic a hormone your gut releases after eating. They slow gastric emptying, reduce appetite, and improve insulin sensitivity. Originally developed for type-2 diabetes, they were later approved for chronic weight management in adults with obesity or overweight with weight-related comorbidities.

Side effects are common in the first few weeks — nausea, constipation, fatigue. Most patients tolerate them with dose escalation handled by their clinician. Serious side effects (pancreatitis, gallbladder issues) are rare but real, which is why clinician oversight matters.

Medications under the GLP-1 umbrella include:

  • Semaglutide (branded as Wegovy for weight loss, Ozempic for diabetes)
  • Tirzepatide (Zepbound for weight, Mounjaro for diabetes — technically a GIP/GLP-1 dual agonist)
  • Liraglutide (Saxenda — older, less commonly prescribed now)

Compounded versions of semaglutide and tirzepatide were widely available during the FDA shortage period. Following the official end of the shortage in 2025, compounding for these molecules is more restricted but not eliminated — patient-specific compounding under section 503A still happens for documented medical need.

What you should look for

For most people considering a GLP-1 program, three things matter more than the brand on the box:

  • Real clinician review. Avoid any program that approves you in under 60 seconds. Quality care takes a real human reading your intake.
  • Honest eligibility. Most legitimate programs require BMI ≥ 27 with a comorbidity, or BMI ≥ 30. If a program ignores BMI entirely, that's a flag.
  • Side-effect support. When you hit week 3 and are nauseous, you want to message your clinician and hear back the same day — not wait for a refill cycle.

Our take

If you want clean, simple, fast — Henry Meds stands out for its straightforward monthly pricing and quick clinician turnaround. If you have insurance or want broader medication choices, Mochi Health is more flexible. If you want a polished, brand-name experience and don't mind paying a premium, Hims is the established player.

The right program is the one whose pricing, clinician access, and support match how you actually want to be cared for. The differences are real but small — pick one, give it three months, and switch if it's not working.

What to do next

Before signing up anywhere:

  1. Calculate your BMI — most programs require BMI ≥ 27.
  2. List your current medications and any history of pancreatitis, thyroid cancer, or eating disorders. These are common eligibility flags.
  3. Check your state — some programs aren't available in every state, especially for compounded medications.
  4. Read the cancellation policy. Plans differ on refunds and pause options.

GLP-1 medications work best as part of a broader change — nutrition, sleep, movement. The medication is the assist, not the answer.


This article includes affiliate links. We may earn a commission when you sign up through links on this page, at no additional cost to you. Editorial coverage and rankings are not influenced by these relationships.

Like this? Get one a week.

No spam. New comparisons, deals, and explainers — only the useful stuff.

Unsubscribe anytime. We never share your email.